From: Liver transplantation in the critically ill: a multicenter Canadian retrospective cohort study
Covariate | Unadjusted (n= 221) | Model 1 (n= 126) | Model 2 (n= 174) | Model 3 (n= 125) |
---|---|---|---|---|
Age | 0.99 (0.96-1.01) | 0.95 (0.91-0.99) a | 0.98 (0.94-1.01) | 0.95 (0.91-0.99) a |
Gender (female) | 1.06 (0.59-1.89) | 1.51 (0.64-3.57) | 1.02 (0.51-2.05) | 1.58 (0.66-3.80) |
Etiology (HCV versus non-HCV) | 1.28 (0.72-2.28) | 1.78 (0.76-4.14) | 1.63 (0.81-3.28) | 1.72 (0.73-4.03) |
SOFA (admission)b | 0.94 (0.88-0.99) a | Â | Â | Â |
Lactate (admission, natural log)c | 0.52 (0.34-0.79) a | Â | Â | Â |
SOFA (48 hours) | 0.88 (0.82-0.94) a | Â | 0.89 (0.82-0.97) a | 0.92 (0.82-1.04) |
48-hour lactate (natural log) | 0.30 (0.17-0.53) a | 0.29 (0.15-0.53) a | Â | 0.32 (0.17-0.61) a |
χ2 (degrees of freedom) |  | 31.03 (6) | 23.75 (6) | 33.23 (7) |